Pfizer PFE earnings Q1 2021

A girl holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in entrance of displayed Pfizer brand on this illustration taken, October 30, 2020. Dado Ruvic | Reuters Pfizer stated Tuesday it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech on the


A girl holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in entrance of displayed Pfizer brand on this illustration taken, October 30, 2020.

Dado Ruvic | Reuters

Pfizer stated Tuesday it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech on the finish of this month. If the FDA indicators off, the corporate will be capable to market the shot on to shoppers.

In releasing its first-quarter monetary outcomes, the corporate additionally reported $3.5 billion in first-quarter gross sales of its Covid-19 vaccine and reported earnings and income that beat Wall Avenue’s expectations.

Here is how Pfizer did in contrast with what Wall Avenue anticipated, in line with common estimates compiled by Refinitiv:

  • Adjusted EPS: 93 cents per share vs 77 cents anticipated
  • Income: $14.58 billion vs. $13.51 billion anticipated

The corporate now expects full-year gross sales of $26 billion from the vaccine, up from its earlier forecast of about $15 billion.

Shares of Pfizer rose 1.4% after the information.

This can be a creating story. Please verify again for updates.



Supply hyperlink

The Fund Times
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *

Latest Posts

Top Authors

Most Commented

Featured Videos